AR071774A1 - Sal de acetato de un compuesto peptidico que tiene actividad antitumoral y su uso. - Google Patents
Sal de acetato de un compuesto peptidico que tiene actividad antitumoral y su uso.Info
- Publication number
- AR071774A1 AR071774A1 ARP090101720A ARP090101720A AR071774A1 AR 071774 A1 AR071774 A1 AR 071774A1 AR P090101720 A ARP090101720 A AR P090101720A AR P090101720 A ARP090101720 A AR P090101720A AR 071774 A1 AR071774 A1 AR 071774A1
- Authority
- AR
- Argentina
- Prior art keywords
- arg
- acetate salt
- peptidic compound
- cbp501
- prodrugs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Adem s provee un metodo para la profilaxis o el tratamiento del c ncer en un mam¡fero, que comprende administrar una cantidad terapeuticamente efectiva de CBP501, una de sus prodrogas o una de sus sales farmaceuticamente aceptables al mam¡fero, en donde CBP501, una de sus prodrogas o una de sus sales farmaceuticamente aceptables es administrada simult neamente con, o antes de, la administracion de un agente que dana el cido nucleico. Reivindicacion 1: Una sal acetato de un compuesto pept¡dico caracterizado por la secuencia: (d-Bpa) (d-Ser) (d-Trp) (d- Ser) (d-Phe-2,3,4,5, 6-F) (d-Cha) (d-Arg) (d-Arg) (d-Arg) (d-Gln) (d-Arg) (d-Arg) (SEQ ID Nø:1). Reivindicacion 2: Un agente para la profilaxis o el tratamiento de un trastorno proliferativo celular, caracterizado porque comprende la sal acetato del compuesto pept¡dico de acuerdo con la reivindicacion 1 como un ingrediente activo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5319008P | 2008-05-14 | 2008-05-14 | |
| US11684908P | 2008-11-21 | 2008-11-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR071774A1 true AR071774A1 (es) | 2010-07-14 |
Family
ID=40886711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090101720A AR071774A1 (es) | 2008-05-14 | 2009-05-13 | Sal de acetato de un compuesto peptidico que tiene actividad antitumoral y su uso. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20100112089A1 (es) |
| CN (1) | CN102149725A (es) |
| AR (1) | AR071774A1 (es) |
| CL (1) | CL2009001156A1 (es) |
| PE (1) | PE20091924A1 (es) |
| RU (1) | RU2010150964A (es) |
| TW (1) | TW201000116A (es) |
| UY (1) | UY31826A (es) |
| WO (1) | WO2009139497A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114966050A (zh) * | 2012-03-18 | 2022-08-30 | 镜株式会社 | 疾病样品分析装置、分析系统及分析方法 |
| KR102247493B1 (ko) * | 2013-06-24 | 2021-04-30 | 가부시키가이샤 캔버스 | 암 환자 하위집단을 위한 복합 용도 및 치료에서 펩티드 및 펩티드모방체 |
| GB201401877D0 (en) | 2014-02-04 | 2014-03-19 | Univ Tromsoe | Peptides |
| TWI805542B (zh) * | 2015-10-23 | 2023-06-21 | 日商坎巴斯有限公司 | 用於癌症治療之肽及擬肽與ｔ細胞活化劑及／或查核點抑制劑之組合 |
| US10149887B2 (en) * | 2015-10-23 | 2018-12-11 | Canbas Co., Ltd. | Peptides and peptidomimetics in combination with t cell activating and/or checkpoint inhibiting agents for cancer treatment |
| CN108601789A (zh) | 2015-11-20 | 2018-09-28 | 生华生物科技股份有限公司 | 用于治疗癌症的四环喹诺酮类似物组合疗法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1218494E (pt) * | 1999-09-22 | 2005-08-31 | Canbas Co Ltd | Composicoes e metodos para inibir a paragem do ciclo celular g2 e para sensibilizar celulas perante agentes que danificam o adn |
| SI1483290T1 (sl) * | 2002-01-17 | 2009-02-28 | Takeda Pharmaceutical | Peptidi in peptidomimetiki, ki imajo antiproliferacijsko aktivnost in/ali okrepijo sredstva ali obdelave, ki poškodujejo nukleinsko kislino |
| US7125842B2 (en) * | 2003-04-07 | 2006-10-24 | Canbas Co. Ltd. | Anti-fungal compounds and methods of use |
| JP2007501608A (ja) * | 2003-08-08 | 2007-02-01 | 株式会社 キャンバス | 抗癌治療の効力を推定するための感受性試験 |
| AU2006201635A1 (en) * | 2005-10-20 | 2007-05-10 | Ludwig Institute For Cancer Research | Novel inhibitors and methods for their preparation |
| CA2666184A1 (en) * | 2006-10-11 | 2008-04-17 | Medvet Science Pty. Ltd. | The use of a dna damaging agent and a ligand for the treatment of cancer |
-
2009
- 2009-05-13 RU RU2010150964/04A patent/RU2010150964A/ru not_active Application Discontinuation
- 2009-05-13 UY UY0001031826A patent/UY31826A/es not_active Application Discontinuation
- 2009-05-13 PE PE2009000669A patent/PE20091924A1/es not_active Application Discontinuation
- 2009-05-13 US US12/465,536 patent/US20100112089A1/en not_active Abandoned
- 2009-05-13 AR ARP090101720A patent/AR071774A1/es not_active Application Discontinuation
- 2009-05-13 TW TW098115779A patent/TW201000116A/zh unknown
- 2009-05-13 CN CN2009801279086A patent/CN102149725A/zh active Pending
- 2009-05-13 WO PCT/JP2009/059238 patent/WO2009139497A1/en active Application Filing
- 2009-05-13 CL CL2009001156A patent/CL2009001156A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW201000116A (en) | 2010-01-01 |
| RU2010150964A (ru) | 2012-06-20 |
| UY31826A (es) | 2010-01-05 |
| US20100112089A1 (en) | 2010-05-06 |
| PE20091924A1 (es) | 2010-01-04 |
| CL2009001156A1 (es) | 2010-08-27 |
| CN102149725A (zh) | 2011-08-10 |
| WO2009139497A1 (en) | 2009-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20130589A1 (es) | Composiciones y metodos para suministro al sistema nervioso central de arilsulfatasa a | |
| AR071774A1 (es) | Sal de acetato de un compuesto peptidico que tiene actividad antitumoral y su uso. | |
| PE20230169A1 (es) | Suministro al sistema nervioso central de agentes terapeuticos | |
| CY1124910T1 (el) | Μεθοδοι και συνθεσεις για παραδοση στο κνς της αρυλοσουλφατασης α | |
| AR107014A1 (es) | Formulación farmacéutica acuosa | |
| CO6260151A2 (es) | Peptido de cdh3 y agente medicinal que comprende al mismo | |
| AR094178A1 (es) | Derivados de exendina-4 funcionalizada | |
| AR078950A1 (es) | Peptido agonista de la guanilato ciclasa c (gc-c) util para tratamientos de trastornos gastrointestinales | |
| GT200700034A (es) | Composiciones farmaceuticas de antagonistas del anticuerpo anti-cd40 | |
| EA201270167A1 (ru) | Лекарственная форма глатирамера ацетата с уменьшенным объемом и способы введения | |
| ES2531083T3 (es) | Formulaciones estables de polipéptidos y usos de las mismas | |
| AR091413A1 (es) | Formulacion de anticuerpos | |
| NZ598610A (en) | High concentration antibody formulations | |
| SG10201804552WA (en) | Nanoparticle compositions, formulations thereof, and uses therefor | |
| AR068020A1 (es) | Terapia combinada para el cancer de pancreas usando un peptido antigenico y un agente quimioterapeutico | |
| NZ608502A (en) | Polypeptides that bind to human complement component c5 | |
| PE20121528A1 (es) | Metodos para administrar agentes hipoglucemiantes de larga duracion | |
| BR112012000914B8 (pt) | uso de polipeptídeo com atividade condrogênica, método in vitro de indução da diferenciação de células-tronco mesenquimais em condrócitos, e composição farmacêutica para aplicação intra-articular | |
| EP3501532A3 (en) | Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof | |
| AR082805A1 (es) | PEPTIDO O COMPLEJO PEPTIDICO QUE SE UNE A INTEGRINA a2 Y METODOS Y USOS QUE IMPLICAN A LOS MISMOS | |
| MX2014002062A (es) | Nanoparticulas de peptido y usos de las mismas. | |
| NI201200085A (es) | Método para tratar la insuficiencia cardíaca con péptidos tipo estrescopina | |
| BR112013004455A2 (pt) | composições para fornecimento gástrico de agentes ativos | |
| WO2009015382A3 (en) | Novel peptides that enhance tight junction permeability | |
| AR114325A1 (es) | Péptidos de la cadena b de la relaxina lipidados modificados y su uso terapéutico |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |